NEW!  BREAKING NEWS: Top 5 world’s richest people in 2020 Read More

World News

South African Minister Of Health says they are Open To Sell Or Swap AstraZeneca Coronavirus vaccine

1 Mins read

The country worst-hit by the pandemic in Africa has suspended its vaccine rollout — meant to begin with Oxford/AstraZeneca this week — after a study found the jab failed to prevent mild and moderate illness caused by a variant discovered in South Africa dubbed 501Y.V2.

South Africa is considering trading its doses of AstraZeneca’s COVID-19 vaccine, which may be less effective against a local virus variant, and beginning its inoculation campaign with Johnson & Johnson shots instead, the health minister said Wednesday.

The vaccination delay has set back an ambitious plan to inoculate around 40 million people — 67 percent of the population — by the end of 2021.

“Given the outcomes of the efficacy studies (government) will continue with the planned phase one vaccination using the Johnson & Johnson vaccines instead of the AstraZeneca vaccine,” Health Minister Zweli Mkhize told a press briefing.

“The Johnson & Johnson vaccine has been proven effective against the 501Y.V2 variant.”

He did not say when immunisation would begin.

Meantime officials are deciding on the fate of more than a million Oxford/AstraZeneca vaccines already secured from the Serum Institute of India (SII) and set to expire at the end of April, though that date could potentially be adjusted.

Mkhize pointed at several options, including selling or swapping the doses with countries tackling the original coronavirus strain.

Scientific advisors have also suggested administering the vaccine to several thousand people within South Africa to assess whether it can still prevent severe infection from 501Y.V2.

“Depending on their advice, the vaccine will be swapped before the expiry date,” he said, adding that “there are already countries who are asking to sell it to them”.

“Our scientists will continue with further deliberations on the AstraZeneca vaccine use in South Africa,” Mkhize explained, assuring that nothing would go to waste.

The World Health Organization announced later on Wednesday that the Oxford/AstraZeneca formula could be used in settings where “variants are present”, as well as on people over the age of 65.

Related posts
World NewsMetro

See what Trump said reacting to President Biden pulling US troops out of Afghanistan on September 11

1 Mins read
Trump offered his support of President Joe Biden’s plans to bring home American troops from Afghanistan but urged Biden to draw an…
MetroWorld News

Bernie Madoff, The mastermind behind the largest Ponzi scheme in history of an estimated $65 billion, dies in prison at 82

2 Mins read
Bernie Madoff has died in prison after about 12 years into a 150-year prison sentence stemming from fraud charges that bilked thousands…
World NewsBeauty & HealthMetro

US orders a pause on Johnson & Johnson COVID-19 vaccine due to several reported cases of blood clots after administered

1 Mins read
The US, reporting via the Food and Drug Administration (FDA) has ordered the suspension of the Johnson & Johnson COVID-19 vaccine after…
Please SUBSCRIBE for our Latest News


0 0 vote
Article Rating
Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x